Eftilagimod Alfa

Eftilagimod Alfa Uses, Dosage, Side Effects, Food Interaction and all others data.

Eftilagimod Alfa is under investigation in clinical trial NCT02614833 (IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma).

Trade Name Eftilagimod Alfa
Generic Eftilagimod alfa
Eftilagimod alfa Other Names Eftilagimod alfa, Immufact
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Eftilagimod Alfa
Eftilagimod Alfa

Innovators Monograph

You find simplified version here Eftilagimod Alfa


*** Taking medicines without doctor's advice can cause long-term problems.
Share